Morgan Stanley Oncternal Therapeutics, Inc. Transaction History

Morgan Stanley

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 16, 2024	BUY	$0.28 - $0.64 $26,034 - $59,507	92,980 New	92,980 $50,000
Q4 2023 Feb 13, 2024	SELL	$0.28 - $0.64 $1,400 - $3,200	-5,000 Reduced 5.1%	92,980 $50,000
Q3 2023 Nov 15, 2023	SELL	$0.29 - $0.48 $2 - $3	-7 Reduced 0.01%	97,980 $29,000
Q2 2023 Aug 14, 2023	BUY	$0.28 - $0.79 $8,852 - $24,975	31,615 Added 47.63%	97,987 $33,000
Q1 2023 May 15, 2023	SELL	$0.63 - $1.3 $3,558 - $7,343	-5,649 Reduced 7.84%	66,372 $52,000
Q4 2022 Feb 14, 2023	BUY	$0.86 - $22.2 $2,009 - $51,881	2,337 Added 3.35%	72,021 $72,000
Q3 2022 Nov 14, 2022	SELL	$0.83 - $17.8 $311,223 - $6.67 Million	-374,968 Reduced 84.33%	69,684 $62,000
Q2 2022 Oct 27, 2022	SELL	$0.7 - $1.56 $41,940 - $93,467	-59,915 Reduced 11.87%	444,652 $493,000
Q2 2022 Aug 15, 2022	SELL	$0.7 - $1.56 $41,940 - $93,467	-59,915 Reduced 11.87%	444,652 $493,000
Q1 2022 Oct 27, 2022	BUY	$1.37 - $2.43 $82,083 - $145,593	59,915 Added 13.47%	504,567 $702,000
Q1 2022 May 13, 2022	SELL	$1.37 - $2.43 $168,182 - $298,309	-122,761 Reduced 19.57%	504,567 $702,000
Q4 2021 Feb 14, 2022	BUY	$2.27 - $4.39 $225,774 - $436,629	99,460 Added 18.84%	627,328 $1.42 Million
Q3 2021 Nov 15, 2021	BUY	$3.37 - $4.76 $1.78 Million - $2.51 Million	527,868 New	527,868 $2.2 Million

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.